Two quantum chips linked through a 30-meter cooled tube enabled scientists to create certified perfectly random numbers.ETH Zurich Researchers at ETH Zurich have developed a method to generate what ...

In a study published in Nano Energy, researchers from Queen Mary, the University of Warwick, Imperial College London, and Universitas Mercatorum report a highly stable, biodegradable Moisture-Electric ...

Abstract: In the contemporary digital landscape, security has become a vital element of our existence. The growing volume of sensitive information being stored and transmitted over networks ...

We wouldn't blame you for assuming that AI, being a computer, would be better at generating passwords than a human. After all, people use AI to do everything from writing their emails to generating a ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Jon Gilbert is a Features Writer for Android Police. I've covered Android since 2021, focusing on writing features and guides about Android apps and features that directly affect users. I've attended ...

AI drug discovery specialist Generate Biomedicines has raised $400 million in the year’s largest initial public offering to date for a biotechnology firm. The company, which was launched in 2018 by ...

Creating strong passwords means balancing security with memorability, so your accounts stay safe without needing a sticky note on your monitor. Password security tips now favor passphrases—long ...

Generate:Biomedicines' anti-TSLP antibody GB-0895 is currently being evaluated in a pair of phase 3 studies for severe asthma. (Stock photo/Getty Images) Clinical-stage antibody company ...